Understanding ANA: Antinuclear Antibodies, Causes & Autoimmune Diseases
Antinuclear antibodies (ANA) are autoantibodies targeting nuclear components (DNA, histones, nucleoproteins, centromeres, etc.).
Significance
- Screening test for systemic autoimmune diseases
- Positive in: SLE (95–99%), Sjögren's, scleroderma, MCTD, polymyositis, autoimmune hepatitis
- Also positive in: 5–15% healthy people (low titer), infections, medications, aging, cancer
Patterns Matter
- Homogeneous (diffuse) — SLE, drug-induced lupus
- Speckled — Sjögren's, scleroderma, MCTD
- Centromere — limited scleroderma (CREST)
- Nucleolar — diffuse scleroderma
- Rim (peripheral) — SLE (anti-dsDNA)
Interpretation
- Positive ANA ≠ disease — need clinical correlation
- Titer and pattern guide further testing (anti-dsDNA, anti-Smith, anti-Scl-70, etc.)
- Diagnosis requires clinical criteria + serology
Management
Treat underlying disease, not ANA. Rheumatology referral for positive ANA with symptoms.
Illness - Related Articles
- Amblyopia (Lazy Eye) Treatment: Methods & Timing
- Calcium Lactate: Benefits, Uses & Deficiency Management
- Dehydration in Seniors: Symptoms, Risks & Care
- Lower Left Abdominal Pain & Nausea: Causes & When to See a Doctor
- Imodium AD: Contraindications & Important Safety Information
- Pre- & Post-Surgery Nutrition: What to Eat and Avoid
- Understanding Tonsillitis: Causes, Symptoms & Prevention
